Notices - 77 fr 5027 - food and drug administration transparency initiative: exploratory program to increase access to the agency's compliance and enforcement data availability

Federal Register / Vol. 77, No. 21 / Wednesday, February 1, 2012 / Notices
(Pub. L. 92–463), the Centers for Disease the needs of American Indian and include a brief description of the topic Time and Date: 8 a.m.–5 p.m., May 3, 2012 formulas, and other issues affecting the Place: Sheraton Gateway Hotel Atlanta delivery of Head Start services in their Airport, 1900 Sullivan Road, Atlanta, Georgia geographic locations [42 U.S.C. 9835, Status: The meeting will be closed to the DATES: February 15, 2012.
public in accordance with provisions set ADDRESSES: 2012 Office of Head Start
forth in Section 552b(c)(4) and (6), Title 5 represent the tribe. The letter should be U.S.C., and the Determination of the Director, Tribal Consultation Session will be held submitted at least three days in advance Management Analysis and Services Office, Matters To Be Discussed: The meeting will include the initial review, discussion, and 1444 US 131 South, Petoskey, MI 49770. representatives of tribal organizations FOR FURTHER INFORMATION CONTACT:
response to ‘‘Identifying Reasons for Racial/ Ethnic Disparities with Completing the HPV Vaccine Series among Adolescent Females, FOA IP12–004; and Intervention Study to Increase Use of Standing Orders Programs for (202) 401–5964. Additional information Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific SUPPLEMENTARY INFORMATION: The
Review Officer, CDC, 1600 Clifton Road NE., authority to sign Federal Register notices
pertaining to announcements of meetings and Head Start) programs for each of the other committee management activities, for both the Centers for Disease Control and attribution, along with topics of concern logistical information for all Consultation Sessions has been sent to Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease Control and [FR Doc. 2012–2143 Filed 1–31–12; 8:45 am] BILLING CODE 4163–18–P
Yvette Sanchez Fuentes,
DEPARTMENT OF HEALTH AND
[FR Doc. 2012–2166 Filed 1–31–12; 8:45 am] HUMAN SERVICES
BILLING CODE 4184–40–P
Administration for Children and
Families
DEPARTMENT OF HEALTH AND
Tribal Consultation Meetings
HUMAN SERVICES
AGENCY: Administration for Children
Food and Drug Administration
[Docket No. FDA–2009–N–0247]
ACTION: Notice of meetings.
formulas, and other issues affecting the Food and Drug Administration
delivery of Head Start services in their Transparency Initiative: Exploratory
SUMMARY: Pursuant to the Improving
Program To Increase Access to the
will share actions taken and in progress Agency’s Compliance and
Enforcement Data; Availability
Consultation Session to be held between Consultations. AGENCY: Food and Drug Administration,
representatives interested in submitting ACTION: Notice.
SUMMARY: The Food and Drug
availability of a report entitled ‘‘Food must be submitted at least three days in Session is to discuss ways to better meet advance of the session and should Federal Register / Vol. 77, No. 21 / Wednesday, February 1, 2012 / Notices
Compliance and Enforcement Data,’’ as David Dorsey,
part of the Transparency Initiative. This Acting Associate Commissioner for Policy and report includes eight initiatives adopted enforcement data, and (2) determine by the Commissioner of Food and Drugs within 270 days (by January 31, 2012) [FR Doc. 2012–2184 Filed 1–31–12; 8:45 am] BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
FOR FURTHER INFORMATION CONTACT:
HUMAN SERVICES
Food and Drug Administration
Ave., Bldg. 32, rm. 4254, Silver Spring, [Docket No. FDA–2011–N–0003]
Withdrawal of Approval of New Animal
Drug Applications
SUPPLEMENTARY INFORMATION: FDA is
AGENCY: Food and Drug Administration,
entitled ‘‘Food and Drug Administration of availability of this report on October ACTION: Notice.
SUMMARY: The Food and Drug
Data.’’ FDA is responsible for a broad activities. Increasing the transparency of these activities enhances the public’s understanding of the Agency’s decisions proposal, relative priority, and available DATES: Withdrawal of approval is
In a May 6, 2011, memorandum to the would determine whether to adopt any FOR FURTHER INFORMATION CONTACT: John
adopting all eight of the draft proposals published in October 2011 as initiatives SUPPLEMENTARY INFORMATION: The
transparency and public accessibility of TABLE 1—NADAS FOR WHICH APPROVAL IS VOLUNTARILY WITHDRAWN METOPHANE Inhalation (methoxyflurane) .
Medical Developments, International Ltd., 556 Morris Ave., LIQUISONE F with Cerumene (hexamethyltetracosane, Evsco Pharmaceuticals, an Affiliate of IGI, Inc., Box 209, prednisolone, tetracaine, neomycin sulfate).
NEOMYCANE Ophthalmic Ointment (neomycin sulfate) .
Evsco Pharmaceuticals, an Affiliate of IGI, Inc., Box 209, OPTISONE (neomycin sulfate, prednisolone acetate) .
Evsco Pharmaceuticals, an Affiliate of IGI, Inc., Box 209, NORCO T–2 Pre-Pak (tylosin phosphate) .
Norco Mills of Norfolk, Inc., P.O. Box 56, Norfolk, NE Evsco Pharmaceuticals, an Affiliate of IGI, Inc., Box 209, Evsco Pharmaceuticals, an Affiliate of IGI, Inc., Box 209, Evsco Pharmaceuticals, An Affiliate of IGI, Inc., Box 209, CHLORASONE Ophthalmic Ointment (chloramphenicol, Evsco Pharmaceuticals, an Affiliate of IGI, Inc., Box 209, BENZA–PEN (penicillin G benzathine, penicillin G procaine) Walco International, Inc., 15 West Putnam, Porterville, CA

Source: http://www.setonresourcecenter.net/register/2012/feb/01/2012-2184.pdf